Conferences - Visterra

Effect of Sibeprenlimab on eGFR in Adults With IgA Nephropathy: A Prespecified Interim Analysis of the VISIONARY Phase 3 Trial

June 3, 2026 | 63rd ERA Congress

V. Perkovic, et al.

Effect of Sibeprenlimab on eGFR in Adults With IgA Nephropathy: A Prespecified Interim Analysis of the VISIONARY Phase 3 Trial

V. Perkovic,¹ J. Hafkin,^2,a J. Xia,² J. Barratt,³ on behalf of the VISIONARY Steering Committee

>SEE POSTER

Identification of VHH-Binders From an Antibody Repertoire Using Computational Methods

October 14, 2025 | Computational Drug Development for Biologics Summit 2025

Identification of VHH-Binders From an Antibody Repertoire Using Computational Methods

Andrew Wollacott

Computational Selection of VHH Binders from Repertoire Sequencing

September 28, 2025 | Discovery on Target

Computational Selection of VHH Binders from Repertoire Sequencing

Nick Woodall

Targeting APRIL and BAFF pathways: Divergent effects on immune populations and protective immunity, with implications for IgAN management

September 17, 2025 | International IgA Nephropathy Network Symposium

Kirk J. Rowley, et al.

Targeting APRIL and BAFF pathways: Divergent effects on immune populations and protective immunity, with implications for IgAN management

Kirk J. Rowley, Vinay Singh, Anna Roberts, Katherine A. Heang, Prashanna B. Venkatasubramanian, Jacob V. Konakondla, Daved Fared, Michelle Lu, Brett Hurst, Wayne W. Hancock, Gregory J. Babcock, Luke N. Robinson

>SEE POSTER

Mutein IL-2 attenuates antibody-mediated rejection in murine kidney transplantation

August 5, 2025 | World Transplant Congress

Yoshikazu Ganchiku, et al.

Mutein IL-2 attenuates antibody-mediated rejection in murine kidney transplantation

Yoshikazu Ganchiku, Rodrigo Benedetti Gassen, Orhan Efe, Zach Shriver, Gregory J. Babcock, Thiago de Jesus Borges, Leonardo V. Riella

Five Strategies to Use IL-2 Muteins to Expand Foxp3+ Treg Cells and Promote Long-term Cardiac and Renal Allograft Survival in Naïve and Sensitized Recipients

August 5, 2025 | World Transplant Congress

Liqing Wang, et al.

Five Strategies to Use IL-2 Muteins to Expand Foxp3+ Treg Cells and Promote Long-term Cardiac and Renal Allograft Survival in Naïve and Sensitized Recipients

Liqing Wang, Luke N. Robinson, Gregory J. Babcock, Wayne W. Hancock

An IL-2 Mutein (VIS171) Induces Regulatory T Cells and Prolongs Survival in a Rhesus Kidney Transplant Model

August 5, 2025 | World Transplant Congress

Davide Schiliró, et al.

An IL-2 Mutein (VIS171) Induces Regulatory T Cells and Prolongs Survival in a Rhesus Kidney Transplant Model

Davide Schiliró, Matthew Tunbridge, Alessandro Martinino, Joe M. Ladowski, Nagham Bazzi, Meghan Hu, Allie Schwalb, Kyo Won Lee, Min Jung Kim, Zishen Li, Janghoon Yoon, Angela Park, Rafaela Belloni, Zheng Chen, John J. O’Neil, Asher D. Schachter, David Oldach, Gregory J. Babcock, Kyha Williams, Jean Kwun, Stuart Knechtle

Selective Enrichment and Functional Preservation of Treg Cells During IL-2 Mutein-Mediated Expansion and Contraction

August 2, 2025 | World Transplant Congress

Davide Schiliró, et al.

Selective Enrichment and Functional Preservation of Treg Cells During IL-2 Mutein-Mediated Expansion and Contraction

Davide Schiliró, Ming Sun, Joshua Lopez, Tammy Tollison, Ethan Smith, Matt Tunbridge, Alessandro Martinino, John J. O’Neil, Asher D. Schachter, David Oldach, Gregory J. Babcock, Stuart Knechtle, Xinxia Peng, H. Kay Chung, Jean Kwun

C5aR1 inhibition ameliorates DGF in a DCD porcine kidney auto-transplantation model

August 2, 2025 | World Transplant Congress

Nader Abraham, et al.

C5aR1 inhibition ameliorates DGF in a DCD porcine kidney auto-transplantation model

Nader Abraham, John J. O’Neil, Mohamed Diab, Ahmed Hassan, Ewout Muylle, Nihal Aykun, Bangchen Wang, David Oldach, Mohit Mathur, Tressa Hood, Benjamin Hughe, Andrew S. Barbas

Sibeprenlimab for Patients With IgA Nephropathy: Results From a Prespecified Interim Analysis of the Phase 3 VISIONARY Study

June 6, 2025 | 62nd ERA Congress

Vlado Perkovic, et al.

Sibeprenlimab for Patients With IgA Nephropathy: Results From a Prespecified Interim Analysis of the Phase 3 VISIONARY Study

Vlado Perkovic, Jonathan Barratt, Richard Lafayette, Adrian Liew, Yusuke Suzuki, Kevin Carroll, Chee Kay Cheung, Vladimir Tesař, Hernán Trimarchi, Muh Geot Wong, Hong Zhang, Dana V. Rizk

>SEE PRESENTATION